ArmitaBahramiMD

Dermatopathology, Molecular Genetics, Anatomic Pathology, Surgical Pathology

Assistant Professor, Pathology, St. Jude Children's Research Hospital and University of Tennessee Health Science Center College of Medicine

Dr. Bahrami is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
262 Danny Thomas Pl
Memphis, TN 38105
Phone+1 901-595-3300

Fax+1 901-595-3100

Mayo Clinic College of Medicine and Science (Rochester) Surgical PathologyFellowship, Selective Pathology, 2009 - 2010
Baylor College of MedicineResidency, Pathology-Anatomic and Clinical, 2004 - 2008
Tehran University of Medical Sciences School of MedicineClass of 1995

PubMed

1 citations
Evaluation and Surgical Management of Pediatric Cutaneous Melanoma and Atypical Spitz and Non-Spitz Melanocytic Tumors (Melanocytomas): A Report From Children's Oncolo...
Michael R Sargen, Raymond L Barnhill, David E Elder, Susan M Swetter, Victor G Prieto
Journal of Clinical Oncology. 2024-10-04
Genomic Insights Into High-Grade Infarct-Associated Bone Sarcomas.
Tatiana Tvrdik, Sandra Gjorgova Gjeorgjievski, Philip Wong, Shervin Oskouei, William Read
Modern Pathology. 2024-10-01
1 citations
Myoepithelial Tumors of Bone With EWSR1::PBX3 Fusion: A Spectrum From Benign to Malignant.
Jatin S Gandhi, Thomas Schneider, Judith J Thangaiah, Scott R Lauer, Sandra Gjorgova Gjeorgjievski
Modern Pathology. 2024-07-01

Journal Articles

Clinical Genome Sequencing Uncovers Potentially Targetable Truncations and Fusions of MAP3K8 in Spitzoid and Other Melanomas
Alberto Pappo, Armita Bahrami, Elizabeth M Azzato, Kim E Nichols, David W Ellison, Nature
Histiocyte-Rich Rhabdomyoblastic Tumor: Rhabdomyosarcoma, Rhabdomyoma, or Rhabdomyoblastic Tumor of Uncertain Malignant Potential? A Histologically Distinctive Rhabdom...
Sharon W Weiss, Andrew L Folpe, Karen J Fritchie, Armita Bahrami, Nature
Article Identification of Therapeutic Targets in Rhabdomyosarcoma Through Integrated Genomic, Epigenomic, and Proteomic Analyses
Armita Bahrami, Alberto Pappo, ScienceDirect

Melanoma Registry Results Shine Light on Rare Pediatric CancerJuly 6th, 2021
Genomic Testing of a Single Patient Reveals a Gene Commonly Mutated in Pediatric MelanomaMarch 5th, 2019